Literature DB >> 3428294

Adrenocortical insufficiency associated with Epstein-Barr virus infection in a patient with the Wiskott-Aldrich syndrome.

N T Hertel1, B B Jacobsen, F K Pedersen, C Heilmann.   

Abstract

A 10-year-old boy with the Wiskott-Aldrich syndrome developed adrenocortical insufficiency including typical clinical findings, low s-Na, high s-K, high p-ACTH (640 ng/l), low p-aldosterone (33-39 pmol/l), high p-renin (2300-4200 mIU/l) as well as an abnormal response to an ACTH-stimulation test. The adrenocortical insufficiency developed concomitantly with the occurrence of infectious mononucleosis diagnosed clinically and serologically. Adrenalitis caused by Epstein-Barr virus is suggested as the causative factor.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3428294     DOI: 10.1007/BF02467365

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  13 in total

1.  Immune function in chronic active Epstein-Barr virus infection.

Authors:  R Kibler; D O Lucas; M J Hicks; B T Poulos; J F Jones
Journal:  J Clin Immunol       Date:  1985-01       Impact factor: 8.317

2.  Wiskott-Aldrich syndrome and Epstein-Barr virus-induced lymphoproliferation.

Authors:  M Okano; F Mizuno; T Osato; Y Takahashi; Y Sakiyama; S Matsumoto
Journal:  Lancet       Date:  1984-10-20       Impact factor: 79.321

3.  Adrenal insufficiency as a complication of the acquired immunodeficiency syndrome.

Authors:  L W Greene; W Cole; J B Greene; B Levy; E Louie; B Raphael; J Waitkevicz; M Blum
Journal:  Ann Intern Med       Date:  1984-10       Impact factor: 25.391

Review 4.  Epstein-Barr virus and the X-linked lymphoproliferative syndrome.

Authors:  J L Sullivan
Journal:  Adv Pediatr       Date:  1983

5.  Chronic active Epstein-Barr virus infections in two immunodeficient patients.

Authors:  D Hellmann; M J Cowan; A J Ammann; D W Wara; D Chudwin; R S Chang
Journal:  J Pediatr       Date:  1983-10       Impact factor: 4.406

6.  Adrenal necrosis in the acquired immunodeficiency syndrome.

Authors:  M L Tapper; H Z Rotterdam; C W Lerner; K Al'Khafaji; P A Seitzman
Journal:  Ann Intern Med       Date:  1984-02       Impact factor: 25.391

7.  Epstein-Barr virus-induced immunoglobulin synthesis by B cells from individuals with late-onset panhypogammaglobulinemia.

Authors:  P L Haber; H Kubagawa; M D Cooper
Journal:  J Clin Immunol       Date:  1983-07       Impact factor: 8.317

8.  Epstein-Barr serology in immunodeficiencies: an attempt to correlate with immune abnormalities in Wiskott-Aldrich and Chediak-Higashi syndromes and ataxia telangiectasia.

Authors:  E Vilmer; G M Lenoir; J L Virelizier; C Griscelli
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

9.  Genetically determined immunodeficiency diseases (GDID) and malignancy: report from the immunodeficiency--cancer registry.

Authors:  B D Spector; G S Perry; J H Kersey
Journal:  Clin Immunol Immunopathol       Date:  1978-09

10.  Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation.

Authors:  R Parkman; J Rappeport; R Geha; J Belli; R Cassady; R Levey; D G Nathan; F S Rosen
Journal:  N Engl J Med       Date:  1978-04-27       Impact factor: 91.245

View more
  4 in total

Review 1.  The potential role for infections in the pathogenesis of autoimmune Addison's disease.

Authors:  A Hellesen; E Bratland
Journal:  Clin Exp Immunol       Date:  2018-09-30       Impact factor: 4.330

2.  Primary adrenal failure due to viral infection in an infant.

Authors:  Leyla Akin; Selim Kurtoglu; Mustafa Kendirci; Mustafa Ali Akin; Fatih Kardas
Journal:  Eur J Pediatr       Date:  2009-11-20       Impact factor: 3.183

3.  The effect of types I and III interferons on adrenocortical cells and its possible implications for autoimmune Addison's disease.

Authors:  A Hellesen; K Edvardsen; L Breivik; E S Husebye; E Bratland
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

Review 4.  Adrenal infections.

Authors:  William F Paolo; Joshua D Nosanchuk
Journal:  Int J Infect Dis       Date:  2006-02-17       Impact factor: 3.623

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.